0001752724-23-190624.txt : 20230825 0001752724-23-190624.hdr.sgml : 20230825 20230825125124 ACCESSION NUMBER: 0001752724-23-190624 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 PERIOD START: 20231231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY INSTITUTIONAL FUND INC CENTRAL INDEX KEY: 0000836487 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-05624 FILM NUMBER: 231205740 BUSINESS ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 800-548-7786 MAIL ADDRESS: STREET 1: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY DEAN WITTER INSTITUTIONAL FUND INC DATE OF NAME CHANGE: 19990329 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY INSTITUTIONAL FUND INC DATE OF NAME CHANGE: 19920703 0000836487 S000074797 Vitality Portfolio C000233002 Class I MSVDX C000233003 Class A MSVEX C000233004 Class C MSVMX C000233005 Class R6 MSVOX NPORT-P 1 primary_doc.xml NPORT-P false 0000836487 XXXXXXXX S000074797 C000233003 C000233002 C000233004 C000233005 MORGAN STANLEY INSTITUTIONAL FUND INC 811-05624 0000836487 54930067DYRSUSGS4E97 522 FIFTH AVENUE NEW YORK 10036 800-869-6397 Vitality Portfolio S000074797 549300V9WWJX6LPH4Y61 2023-12-31 2023-06-30 N 2393566.86 26246.88 2367319.98 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N GH Research PLC 875500HKJS7QQG6EWH62 GH Research PLC 000000000 958.00000000 NS USD 11366.67000000 0.480149286789 Long EC CORP IE N 1 N N N 10X Genomics Inc 5493003Z6741WNLG7H43 10X Genomics Inc 88025U109 2378.00000000 NS USD 132787.52000000 5.609191876123 Long EC CORP US N 1 N N N HSBC Securities (USA) Inc. CYYGQCGNHMHPSMRL3R97 HSBC TRI PARTY A REPO 000000000 421.08526743 PA USD 421.08526743 0.017787425062 Long RA CORP US N 2 Repurchase Y 5.05000000 2023-07-03 440.19252400 USD 429.50697362 USD UST N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals Inc 02043Q107 419.00000000 NS USD 79584.86000000 3.361812542130 Long EC CORP US N 1 N N N Relay Therapeutics Inc N/A Relay Therapeutics Inc 75943R102 1230.00000000 NS USD 15448.80000000 0.652586052182 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals Inc 92532F100 276.00000000 NS USD 97127.16000000 4.102831928956 Long EC CORP US N 1 N N N UnitedHealth Group Inc 549300GHBMY8T5GXDE41 UnitedHealth Group Inc 91324P102 232.00000000 NS USD 111508.48000000 4.710325640051 Long EC CORP US N 1 N N N Exact Sciences Corp 549300VM3X1FYD4N9Z14 Exact Sciences Corp 30063P105 1207.00000000 NS USD 113337.30000000 4.787578399097 Long EC CORP US N 1 N N N Merrill Lynch, Pierce, Fenner & Smith Incorporated 8NAV47T0Y26Q87Y0QP81 MERRILL LYNCH TRI PARTY A REPO 000000000 336.86821394 PA USD 336.86821394 0.014229940049 Long RA CORP US N 2 Repurchase Y 5.05000000 2023-07-03 340.11057100 USD 343.60766849 USD UST N N agilon health Inc N/A agilon health Inc 00857U107 2814.00000000 NS USD 48794.76000000 2.061181437753 Long EC CORP US N 1 N N N AbCellera Biologics Inc 9845000861BC95FF9F73 AbCellera Biologics Inc 00288U106 3223.00000000 NS USD 20820.58000000 0.879500032775 Long EC CORP CA N 1 N N N Thermo Fisher Scientific Inc HCHV7422L5HDJZCRFL38 Thermo Fisher Scientific Inc 883556102 213.00000000 NS USD 111132.75000000 4.694454105861 Long EC CORP US N 1 N N N Beam Therapeutics Inc N/A Beam Therapeutics Inc 07373V105 1368.00000000 NS USD 43680.24000000 1.845134598154 Long EC CORP US N 1 N N N Ascendis Pharma A/S 549300B66JN3W3J8GH73 Ascendis Pharma A/S 04351P101 261.00000000 NS USD 23294.25000000 0.983992455468 Long EC CORP DK N 1 N N N Intellia Therapeutics Inc 5493002T5BCPE5DZC723 Intellia Therapeutics Inc 45826J105 1593.00000000 NS USD 64962.54000000 2.744138542690 Long EC CORP US N 1 N N N Zoetis Inc 549300HD9Q1LOC9KLJ48 Zoetis Inc 98978V103 340.00000000 NS USD 58551.40000000 2.473320062123 Long EC CORP US N 1 N N N Inspire Medical Systems Inc 549300XQQCQ7HCJKTW25 Inspire Medical Systems Inc 457730109 324.00000000 NS USD 105183.36000000 4.443140804311 Long EC CORP US N 1 N N N Align Technology Inc 549300N5YSE0U3LCP840 Align Technology Inc 016255101 210.00000000 NS USD 74264.40000000 3.137066413810 Long EC CORP US N 1 N N N Veeva Systems Inc 549300YZEXPDB92M2F02 Veeva Systems Inc 922475108 259.00000000 NS USD 51212.07000000 2.163293109197 Long EC CORP US N 1 N N N Moderna Inc 549300EI6OKH5K5Q2G38 Moderna Inc 60770K107 372.00000000 NS USD 45198.00000000 1.909247604119 Long EC CORP US N 1 N N N Morgan Stanley & Co. LLC 549300OJY9IZ31SGS926 Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio 61747C525 148608.04000000 NS USD 148608.04000000 6.277480072634 Long STIV RF US N 1 N N N ATAI Life Sciences NV 391200Z8UWPJSNBNCA11 ATAI Life Sciences NV 000000000 8904.00000000 NS USD 15314.88000000 0.646929022243 Long EC CORP NL N 1 N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina Inc 452327109 289.00000000 NS USD 54184.61000000 2.288858728763 Long EC CORP US N 1 N N N Doximity Inc N/A Doximity Inc 26622P107 1353.00000000 NS USD 46029.06000000 1.944353124582 Long EC CORP US N 1 N N N SomaLogic Inc 549300D3W3Q8CN30YO25 SomaLogic Inc 83444K105 12320.00000000 NS USD 28459.20000000 1.202169552085 Long EC CORP US N 1 N N N Guardant Health Inc 254900M8C3E5VC8BR186 Guardant Health Inc 40131M109 892.00000000 NS USD 31933.60000000 1.348934671687 Long EC CORP US N 1 N N N Fate Therapeutics Inc 549300L14Q4UHOODLA90 Fate Therapeutics Inc 31189P102 1572.00000000 NS USD 7482.72000000 0.316084013281 Long EC CORP US N 1 N N N Intuitive Surgical Inc 54930052SRG011710797 Intuitive Surgical Inc 46120E602 306.00000000 NS USD 104633.64000000 4.419919608839 Long EC CORP US N 1 N N N Argenx SE 7245009C5FZE6G9ODQ71 Argenx SE 04016X101 245.00000000 NS USD 95483.85000000 4.033415457423 Long EC CORP NL N 1 N N N Schrodinger Inc/United States N/A Schrodinger Inc/United States 80810D103 1523.00000000 NS USD 76028.16000000 3.211570917421 Long EC CORP US N 1 N N N Altimmune Inc 549300EOYCQ8SW3NVE64 Altimmune Inc 02155H200 1044.00000000 NS USD 3685.32000000 0.155674772786 Long EC CORP US N 1 N N N Evotec SE 529900F9KI6OYITO9B12 Evotec SE 30050E105 3481.00000000 NS USD 38952.39000000 1.645421418696 Long EC CORP DE N 1 N N N Morgan Stanley & Co. LLC 549300OJY9IZ31SGS926 Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio 61747C525 11369.30222586 NS USD 11369.30222586 0.480260476906 Long STIV RF US N 1 N N Chewy Inc 254900NPQSTG9I422879 Chewy Inc 16679L109 1010.00000000 NS USD 39864.70000000 1.683959090312 Long EC CORP US N 1 N N N Stevanato Group SpA 81560033F7E1CD477507 Stevanato Group SpA 000000000 2691.00000000 NS USD 87134.58000000 3.680726760055 Long EC CORP IT N 1 N N N West Pharmaceutical Services Inc 5493007NKRGM1RJQ1P16 West Pharmaceutical Services Inc 955306105 143.00000000 NS USD 54693.21000000 2.310342938938 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co 532457108 294.00000000 NS USD 137880.12000000 5.824312774143 Long EC CORP US N 1 N N N 4D Molecular Therapeutics Inc N/A 4D Molecular Therapeutics Inc 35104E100 1273.00000000 NS USD 23003.11000000 0.971694160246 Long EC CORP US N 1 N N N MaxCyte Inc 54930053YHXULRFCU991 MaxCyte Inc 57777K106 8127.00000000 NS USD 37302.93000000 1.575745159722 Long EC CORP US N 1 N N N Royalty Pharma PLC 549300FGFN7VOK8BZR03 Royalty Pharma PLC 000000000 1579.00000000 NS USD 48538.46000000 2.050354848946 Long EC CORP GB N 1 N N N IDEXX Laboratories Inc OGMTXK0LUU1HKV2P0J84 IDEXX Laboratories Inc 45168D104 94.00000000 NS USD 47209.62000000 1.994222175238 Long EC CORP US N 1 N N N Citigroup Global Markets Inc MBNUM2BPBDO7JBLYG310 Citigroup Global Markets Inc 000000000 197.99429274 PA USD 197.99429274 0.008363647264 Long RA CORP US N 2 Repurchase Y 5.00000000 2023-07-03 203.06415800 USD 201.86927635 USD UST N N 2023-07-17 MORGAN STANLEY INSTITUTIONAL FUND INC Francis Smith Francis Smith Principal Financial Officer